Literature DB >> 24193917

Zipper interacting protein kinase (ZIPK): function and signaling.

Tatsuya Usui1, Muneyoshi Okada, Hideyuki Yamawaki.   

Abstract

Zipper interacting protein kinase (ZIPK), also known as death associated protein kinase 3, is a serine/threonine kinase that mediates variety of cell functions. The major biologic function of ZIPK is considered to be the regulation of apoptosis and smooth muscle contraction. Recently, several other functions of ZIPK have been gradually clarified. In this review article, we summarized the recent findings on ZIPK function and ZIPK-related cell signaling. We propose that ZIPK is a potential future target for the development of pharmaceutical therapy for cancer as well as cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24193917     DOI: 10.1007/s10495-013-0934-3

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  14 in total

1.  DAPK3 suppresses acini morphogenesis and is required for mouse development.

Authors:  Brandon A Kocher; Lynn S White; David Piwnica-Worms
Journal:  Mol Cancer Res       Date:  2014-10-10       Impact factor: 5.852

2.  DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy.

Authors:  Guan-Man Li; Lei Li; Meng-Qing Li; Xu Chen; Qiao Su; Zhi-Juan Deng; Hai-Bo Liu; Bin Li; Wen-Hui Zhang; Yong-Xu Jia; Wen-Jian Wang; Jie-Yi Ma; Hai-Liang Zhang; Dan Xie; Xiao-Feng Zhu; Yu-Long He; Xin-Yuan Guan; Jiong Bi
Journal:  Cell Death Differ       Date:  2020-10-09       Impact factor: 15.828

3.  Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.

Authors:  Jian Li; Zhijuan Deng; Zhu Wang; Dong Wang; Longjuan Zhang; Qiao Su; Yingrong Lai; Bin Li; Zexing Luo; Xu Chen; Yu Chen; Xiaohui Huang; Jieyi Ma; Wenjian Wang; Jiong Bi; Xinyuan Guan
Journal:  Oncotarget       Date:  2015-04-10

4.  Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.

Authors:  N Miyoshi; B S Wittner; K Shioda; T Hitora; T Ito; S Ramaswamy; K J Isselbacher; D C Sgroi; T Shioda
Journal:  Oncogenesis       Date:  2015-10-19       Impact factor: 7.485

5.  The effects of knockdown of rho-associated kinase 1 and zipper-interacting protein kinase on gene expression and function in cultured human arterial smooth muscle cells.

Authors:  Jing-Ti Deng; Xiu-Ling Wang; Yong-Xiang Chen; Edward R O'Brien; Yu Gui; Michael P Walsh
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

6.  Characterization of the zebrafish homolog of zipper interacting protein kinase.

Authors:  Brandon W Carr; Tamara L Basepayne; Lawrence Chen; Vaishali Jayashankar; Douglas C Weiser
Journal:  Int J Mol Sci       Date:  2014-06-30       Impact factor: 5.923

7.  RhoD Inhibits RhoC-ROCK-Dependent Cell Contraction via PAK6.

Authors:  Charlotte H Durkin; Flavia Leite; João V Cordeiro; Yutaka Handa; Yoshiki Arakawa; Ferran Valderrama; Michael Way
Journal:  Dev Cell       Date:  2017-05-08       Impact factor: 12.270

8.  Cooperativity between β-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation.

Authors:  Ajay P Nayak; John M Lim; Eylon Arbel; Ruping Wang; Dominic R Villalba; Tahn L Nguyen; Niccole Schaible; Ramaswamy Krishnan; Dale D Tang; Raymond B Penn
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

9.  A novel inhibitory effect of oxazol-5-one compounds on ROCKII signaling in human coronary artery vascular smooth muscle cells.

Authors:  Abdulhameed Al-Ghabkari; Jing-Ti Deng; Paul C McDonald; Shoukat Dedhar; Mana Alshehri; Michael P Walsh; Justin A MacDonald
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

10.  RNAi-Based Identification of Gene-Specific Nuclear Cofactor Networks Regulating Interleukin-1 Target Genes.

Authors:  Johanna Meier-Soelch; Liane Jurida; Axel Weber; Doris Newel; Johnny Kim; Thomas Braun; M Lienhard Schmitz; Michael Kracht
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.